Pavan Drugs & Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
- Paid Up Capital ₹ 5.23 M
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2014
- Satisfied Charges ₹ 9.50 Cr
About Pavan Drugs & Chemicals
Pavan Drugs & Chemicals Private Limited (PDCPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 September 2008 and has a history of 16 years and four months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 5.23 M.
The company has closed loans amounting to ₹9.50 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233TG2008PTC060952
-
Company No.
060952
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Sep 2008
-
Date of AGM
29 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pavan Drugs & Chemicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkataramana Yarlagadda
|
Director | 09-Sep-2008 | Current |
|
Sudha Yarlagadda
|
Director | 09-Sep-2008 | Current |
Financial Performance of Pavan Drugs & Chemicals.
Enhance accessibility to Pavan Drugs & Chemicals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pavan Drugs & Chemicals?
Unlock access to Pavan Drugs & Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Pragathi Organics LimitedVenkataramana Yarlagadda and Sudha Yarlagadda are mutual person
Charges (Loans)
₹0
₹95.00 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 9.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2010 | Bank Of Baroda | ₹8.00 Cr | Satisfied |
| 25 Aug 2009 | Bank Of Baroda | ₹1.50 Cr | Satisfied |
How Many Employees Work at Pavan Drugs & Chemicals?
Unlock and access historical data on people associated with Pavan Drugs & Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pavan Drugs & Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pavan Drugs & Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.